Related Experiment Video
Updated: Jan 6, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Clinical Prediction Models for Valvular Heart Disease
Benjamin S Wessler1,2, Christine M Lundquist1, Benjamin Koethe1
1Predictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA.
Insights
Many clinical prediction models (CPMs) for valvular heart disease lack external validation, with most showing decreased performance in new populations. More validation is needed, especially for transcatheter aortic valve replacement models.
Area of Science:
- Cardiology
- Medical Informatics
- Health Services Research
Background:
- Numerous clinical prediction models (CPMs) exist for valvular heart disease (VHD) treatment decisions.
- The comparative performance and external validation of these VHD CPMs are not well understood.
Purpose of the Study:
- To systematically review and describe available CPMs for VHD.
- To specifically assess the performance of these CPMs in external validation studies.
Main Methods:
- A systematic review identified 49 CPMs for VHD patients undergoing surgery, percutaneous intervention, or no intervention.
- Analyzed 204 external validations across these CPMs, noting populations and performance metrics.
Main Results:
- Only 71% of identified CPMs have undergone external validation.
- 65% of external validations used distantly related populations, showing a median -27.1% change in discrimination.
- EuroSCORE II and STS (2009) models showed variable performance but performed better in related populations; few validations exist for transcatheter aortic valve replacement CPMs.
Conclusions:
- Many VHD CPMs lack external validation, and isolated validations are insufficient to confirm trustworthiness.
- Existing surgical VHD models perform adequately in related populations.
- Transcatheter aortic valve replacement CPMs require additional external validation to ensure reliable predictions.
Abstract:
Background While many clinical prediction models (CPMs) exist to guide valvular heart disease treatment decisions, the relative performance of these CPMs is largely unknown. We systematically describe the CPMs available for patients with valvular heart disease with specific attention to performance in external validations. Methods and Results A systematic review identified 49 CPMs for patients with valvular heart disease treated with surgery (n=34), percutaneous interventions (n=12), or no intervention (n=3). There were 204 external validations of these CPMs. Only 35 (71%) CPMs have been externally validated. Sixty-five percent (n=133) of the external validations were performed on distantly related populations. There was substantial heterogeneity in model performance and a median percentage change in discrimination of -27.1% (interquartile range, -49.4%--5.7%). Nearly two-thirds of validations (n=129) demonstrate at least a 10% relative decline in discrimination. Discriminatory performance of EuroSCORE II and Society of Thoracic Surgeons (2009) models (accounting for 73% of external validations) varied widely: EuroSCORE II validation c-statistic range 0.50 to 0.95; Society of Thoracic Surgeons (2009) Models validation c-statistic range 0.50 to 0.86. These models performed well when tested on related populations (median related validation c-statistics: EuroSCORE II, 0.82 [0.76, 0.85]; Society of Thoracic Surgeons [2009], 0.72 [0.67, 0.79]). There remain few (n=9) external validations of transcatheter aortic valve replacement CPMs. Conclusions Many CPMs for patients with valvular heart disease have never been externally validated and isolated external validations appear insufficient to assess the trustworthiness of predictions. For surgical valve interventions, there are existing predictive models that perform reasonably well on related populations. For transcatheter aortic valve replacement (CPMs additional external validations are needed to broadly understand the trustworthiness of predictions.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
09:20Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis IV: Nursing Management